HRT Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-664,987
| Closed | -$17.7M | – | 4502 |
|
|
2025
Q4 | $16.6M | Buy |
+664,987
| New | +$16.8M | 0.05% | 282 |
|
|
2025
Q2 | – | Sell |
-5,500,025
| Closed | -$128M | – | 3324 |
|
|
2025
Q1 | $139M | Buy |
+5,500,025
| New | +$144M | 0.88% | 12 |
|
|
2024
Q4 | – | Sell |
-956,803
| Closed | -$27.7M | – | 3031 |
|
|
2024
Q3 | $27.7M | Buy |
956,803
+553,067
| +137% | +$16.1M | 0.14% | 80 |
|
|
2024
Q2 | $11.3M | Sell |
403,736
-75,915
| -16% | -$2.09M | 0.06% | 225 |
|
|
2024
Q1 | $13.3M | Buy |
479,651
+227,386
| +90% | +$6.31M | 0.08% | 117 |
|
|
2023
Q4 | $7.26M | Buy |
252,265
+220,902
| +704% | +$6.68M | 0.05% | 210 |
|
|
2023
Q3 | $1.04M | Buy |
+31,363
| New | +$1.11M | 0.01% | 942 |
|
|
2022
Q4 | – | Sell |
-81,492
| Closed | -$3.91M | – | 2973 |
|
|
2022
Q3 | $3.57M | Buy |
+81,492
| New | +$3.96M | 0.04% | 397 |
|
|
2022
Q2 | – | Sell |
-92,379
| Closed | -$4.78M | – | 3537 |
|
|
2022
Q1 | $4.78M | Sell |
92,379
-1,261,246
| -93% | -$65.4M | 0.03% | 301 |
|
|
2021
Q4 | $79.9M | Buy |
1,353,625
+945,521
| +232% | +$46.8M | 0.46% | 14 |
|
|
2021
Q3 | $17.6M | Buy |
+408,104
| New | +$18.1M | 0.11% | 93 |
|
|
2021
Q2 | – | Sell |
-350,765
| Closed | -$12.7M | – | 3364 |
|
|
2021
Q1 | $12.7M | Buy |
+350,765
| New | +$12.5M | 0.13% | 105 |
|
|
2020
Q3 | – | Sell |
-282,064
| Closed | -$8.75M | – | 2238 |
|
|
2020
Q2 | $8.75M | Buy |
+282,064
| New | +$9.58M | 0.26% | 70 |
|
|
2019
Q4 | – | Sell |
-27,867
| Closed | -$949K | – | 1524 |
|
|
2019
Q3 | $949K | Sell |
27,867
-133,396
| -83% | -$4.85M | 0.04% | 380 |
|
|
2019
Q2 | $6.63M | Buy |
161,263
+28,158
| +21% | +$1.12M | 0.42% | 52 |
|
|
2019
Q1 | $5.36M | Sell |
133,105
-72,378
| -35% | -$2.9M | 0.83% | 19 |
|
|
2018
Q4 | $8.51M | Buy |
205,483
+200,563
| +4,076% | +$8.33M | 1.22% | 16 |
|
|
2018
Q3 | $205K | Buy |
+4,920
| New | +$189K | 0.03% | 327 |
|
|
2018
Q2 | – | Sell |
-6,418
| Closed | -$216K | – | 344 |
|
|
2018
Q1 | $216K | Sell |
6,418
-24,550
| -79% | -$844K | 0.1% | 158 |
|
|
2017
Q4 | $1.06M | Buy |
+30,968
| New | +$1.06M | 1.08% | 14 |
|
|
2017
Q3 | – | Sell |
-8,280
| Closed | -$263K | – | 129 |
|
|
2017
Q2 | $263K | Sell |
8,280
-1,271
| -13% | -$40.1K | 0.42% | 33 |
|
|
2017
Q1 | $310K | Buy |
+9,551
| New | +$301K | 0.29% | 50 |
|
|
2016
Q3 | – | Sell |
-25,424
| Closed | -$849K | – | 164 |
|
|
2016
Q2 | $849K | Buy |
+25,424
| New | +$811K | 0.52% | 31 |
|
|
2015
Q2 | – | Sell |
-9,826
| Closed | -$324K | – | 187 |
|
|
2015
Q1 | $324K | Sell |
9,826
-6,446
| -40% | -$205K | 0.41% | 29 |
|
|
2014
Q4 | $480K | Buy |
+16,272
| New | +$467K | 0.68% | 20 |
|
Other funds holding PFE
VCM
VPM
HRT Financial's PFE Position: Q1 2026 in Review
HRT Financial sold out of Pfizer (PFE) in Q1 2026, closing a stake of 664,987 shares — an estimated $17.7M sold.
HRT Financial first reported a position in PFE in Q4 2014 and held it in 25 quarters. The position peaked at $139M in Q1 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- HRT Financial reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- HRT Financial sold 664,987 Pfizer shares in Q1 2026, an estimated $17.7M.
- HRT Financial first reported a position in Pfizer in Q4 2014 and held it in 25 quarters.
- HRT Financial's Pfizer position peaked at $139M in Q1 2025.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.